CA2223522A1 - Use of 5-aminolevulinic acid for treating or detecting rapidly growing cells of exogenous origin - Google Patents

Use of 5-aminolevulinic acid for treating or detecting rapidly growing cells of exogenous origin

Info

Publication number
CA2223522A1
CA2223522A1 CA002223522A CA2223522A CA2223522A1 CA 2223522 A1 CA2223522 A1 CA 2223522A1 CA 002223522 A CA002223522 A CA 002223522A CA 2223522 A CA2223522 A CA 2223522A CA 2223522 A1 CA2223522 A1 CA 2223522A1
Authority
CA
Canada
Prior art keywords
treating
aminolevulinic acid
rapidly growing
growing cells
exogenous cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002223522A
Other languages
French (fr)
Other versions
CA2223522C (en
Inventor
James C. Kennedy
Roy H. Pottier
Robert L. Reid
Arnold Sac-Morales
Lewis L. Tomalty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University at Kingston
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/465,242 external-priority patent/US5955490A/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/CA1996/000363 external-priority patent/WO1996039188A1/en
Publication of CA2223522A1 publication Critical patent/CA2223522A1/en
Application granted granted Critical
Publication of CA2223522C publication Critical patent/CA2223522C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Methods of detecting and treating rapidly growing exogenous cells, such as Protista, or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluroescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.
CA002223522A 1995-06-05 1996-06-03 Use of 5-aminolevulinic acid for treating or detecting rapidly growing cells of exogenous origin Expired - Lifetime CA2223522C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/465,242 US5955490A (en) 1989-07-28 1995-06-05 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US08/465,242 1995-06-05
PCT/CA1996/000363 WO1996039188A1 (en) 1995-06-05 1996-06-03 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins

Publications (2)

Publication Number Publication Date
CA2223522A1 true CA2223522A1 (en) 1996-12-12
CA2223522C CA2223522C (en) 2009-02-10

Family

ID=23847002

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002223522A Expired - Lifetime CA2223522C (en) 1995-06-05 1996-06-03 Use of 5-aminolevulinic acid for treating or detecting rapidly growing cells of exogenous origin

Country Status (6)

Country Link
AT (1) ATE287709T1 (en)
AU (1) AU5888796A (en)
CA (1) CA2223522C (en)
DE (1) DE69634250T2 (en)
DK (1) DK0831909T3 (en)
ES (1) ES2236731T3 (en)

Also Published As

Publication number Publication date
AU5888796A (en) 1996-12-24
CA2223522C (en) 2009-02-10
ES2236731T3 (en) 2005-07-16
DE69634250T2 (en) 2006-03-30
DE69634250D1 (en) 2005-03-03
DK0831909T3 (en) 2005-06-06
ATE287709T1 (en) 2005-02-15

Similar Documents

Publication Publication Date Title
AU693171B2 (en) Methods for phototherapeutic treatment of proliferative skin diseases
Choudhary et al. Photodynamic therapy in dermatology: a review
Ennever Blue light, green light, white light, more light: treatment of neonatal jaundice
US7220778B2 (en) Methods and devices for epithelial protection during photodynamic therapy
CA2134479A1 (en) Laser treatment
CA2155833A1 (en) Photodynamic treatment of synovium
DE69521430D1 (en) RHODAMINE DERIVATIVES FOR THE PHOTODYNAMIC THERAPY OF CANCER AND IN-VITRO CLEANING OF LEUCAMIA
WO1999066831A3 (en) Utilization of 5-aminolevulinic acid or a derivative thereof for photodynamic diagnosis or photodynamic therapy of diseases of the parodontium and teeth
AU696851B2 (en) Method of treating hyperproliferative vascular disease
FI981954A0 (en) Improved vision through photodynamic therapy of the eye
JP3917661B2 (en) Composition useful for phototherapy treatment of proliferative skin disease
RU95118252A (en) MEANS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
RU99117522A (en) PHOTOCHEMOTHERAPEUTIC COMPOSITIONS
DE69826711D1 (en) METHOD FOR TREATING PIGMENTED CANCER CELLS BY PHOTODYNAMIC THERAPY
Chaudhry et al. Relaxation of vascular smooth muscle induced by low‐power laser radiation
EP1120119A4 (en) Remedies for photochemotherapy
EP1510225A3 (en) Photochemotherapeutic and diagnostic application using 5-ALA and precursors
US20080146667A1 (en) Method of treatment of skin
EP0313901A3 (en) System for in vivo treatment of tumorous tissues on body surfaces
CA2270558A1 (en) Treatment of autoimmune diseases by photochemotherapy
CA2223522A1 (en) Use of 5-aminolevulinic acid for treating or detecting rapidly growing cells of exogenous origin
CA2381143A1 (en) Dendrimer-photosensitizer complexes for medical applications
CA2210109A1 (en) Method to prevent transplant rejection
RU2003126736A (en) METHOD OF THERAPY AND MONITORING OF THE PROCESS OF TREATMENT OF Cicatrices Arising from the Acne Rash (ACNE VULGARIS)
SU1174042A1 (en) Method of treatment of non-infectious diseases of liver complicated by jaundice

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20160603